BUSPIRONE HYDROCHLORIDE Recall D-0549-2023
Description: BusPIRone Hydrochloride Tablets USP, 7.5 mg, 30-count bottles, Rx Only, Repackaged By: NOrthwind Pharmaceuticals, Indianapolis, IN 46203. NDC 51655-511-52
BUSPIRONE HYDROCHLORIDE Recall D-0549-2023 Information
| Status | Ongoing |
| Mandated? | Voluntary: Firm initiated |
| Recall Number | D-0549-2023 |
| Event ID | 91944 |
| Brand | BUSPIRONE HYDROCHLORIDE |
| Generic Name | BUSPIRONE HYDROCHLORIDE |
| Manufacturer | BUSPIRONE HYDROCHLORIDE |
| Active Substance | BUSPIRONE HYDROCHLORIDE |
| Drug Route | ORAL |
| Distribution | Nationwide with the United States |
| Quantity | 6 bottles |
| Recall Reason | CGMP Deviations |
| Drug Classification | Class II |
| Drug Code Info | 20230503 |
| Product NDC | 51655-511 |
| Recall Initiation Date | 20230316 |
| Report Date | 20230503 |
| Classification Date | 20230426 |
| Address | 4838 Fletcher Ave Ste 1000 Indianapolis, IN 46203-1642 United States |
| Recalling Firm | Northwind Pharmaceuticals LLC |
| Initial Notification | Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit |
| Unique Ingredient Identifier | 207LT9J9OC |
| Drug Application Number | ANDA202557 |
| Structured Product Labeling (SPL ID) | f318a6d5-6b1b-f16e-e053-2a95a90a3d95 |
| Structured Product Labeling (SPL Set ID) | f318ba7b-121f-2e4f-e053-2a95a90a60c5 |
| Similar To |